Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omitting the Boost to Initially Involved But Undissected Nodal Stations That Achieved Clinical Complete Response After Neoadjuvant Systemic Therapy in cN3 Breast Cancer: A Phase III Randomized Study

NCT07829848 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07829848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07829848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omitting the Boost to Initially Involved But Undissected Nodal Stations That Achieved Clinical Complete Response After Neoadjuvant Systemic Therapy in cN3 Breast Cancer: A Phase III Randomized Study
Lead sponsor
Fudan University
Phase
Not applicable
Overall status
Recruiting
Start date
September 12, 2026
Completion date
September 12, 2033
Enrollment
534 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer